Cigna Investments’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $599K | Hold |
14,027
| – | – | 0.08% | 221 |
|
|
2026
Q1 | $880K | Sell |
14,027
-244
| -2% | -$19.5K | 0.14% | 137 |
|
|
2025
Q4 | $1.36M | Sell |
14,271
-170
| -1% | -$16.7K | 0.2% | 93 |
|
|
2025
Q3 | $1.41M | Hold |
14,441
| – | – | 0.2% | 90 |
|
|
2025
Q2 | $1.55M | Sell |
14,441
-335
| -2% | -$33.9K | 0.26% | 67 |
|
|
2025
Q1 | $1.49M | Sell |
14,776
-330
| -2% | -$33.2K | 0.28% | 68 |
|
|
2024
Q4 | $1.35M | Sell |
15,106
-77
| -0.5% | -$6.78K | 0.24% | 79 |
|
|
2024
Q3 | $1.27M | Sell |
15,183
-202
| -1% | -$15.9K | 0.22% | 82 |
|
|
2024
Q2 | $1.19M | Sell |
15,385
-105
| -0.7% | -$7.69K | 0.22% | 91 |
|
|
2024
Q1 | $1.06M | Sell |
15,490
-79
| -0.5% | -$5.08K | 0.2% | 108 |
|
|
2023
Q4 | $900K | Buy |
15,569
+219
| +1% | +$11.7K | 0.19% | 118 |
|
|
2023
Q3 | $811K | Sell |
15,350
-1,991
| -11% | -$104K | 0.18% | 116 |
|
|
2023
Q2 | $938K | Buy |
17,341
+140
| +0.8% | +$7.31K | 0.17% | 115 |
|
|
2023
Q1 | $861K | Sell |
17,201
-418
| -2% | -$19.7K | 0.17% | 120 |
|
|
2022
Q4 | $816K | Buy |
17,619
+47
| +0.3% | +$2.04K | 0.17% | 126 |
|
|
2022
Q3 | $680K | Sell |
17,572
-773
| -4% | -$31K | 0.15% | 140 |
|
|
2022
Q2 | $684K | Sell |
18,345
-6,641
| -27% | -$270K | 0.14% | 156 |
|
|
2022
Q1 | $1.11M | Sell |
24,986
-7,191
| -22% | -$312K | 0.14% | 146 |
|
|
2021
Q4 | $1.37M | Sell |
32,177
-11,368
| -26% | -$478K | 0.11% | 150 |
|
|
2021
Q3 | $1.89M | Sell |
43,545
-744
| -2% | -$32.9K | 0.14% | 131 |
|
|
2021
Q2 | $1.89M | Sell |
44,289
-6,854
| -13% | -$288K | 0.14% | 136 |
|
|
2021
Q1 | $1.98M | Buy |
51,143
+1,246
| +2% | +$47.2K | 0.14% | 138 |
|
|
2020
Q4 | $1.79M | Buy |
49,897
+3,782
| +8% | +$136K | 0.14% | 139 |
|
|
2020
Q3 | $1.76M | Sell |
46,115
-11,085
| -19% | -$427K | 0.17% | 119 |
|
|
2020
Q2 | $2.01M | Buy |
57,200
+17,965
| +46% | +$647K | 0.19% | 105 |
|
|
2020
Q1 | $1.28M | Buy |
39,235
+2,300
| +6% | +$89.8K | 0.16% | 131 |
|
|
2019
Q4 | $1.55M | Sell |
36,935
-9,940
| -21% | -$416K | 0.16% | 148 |
|
|
2019
Q3 | $1.96M | Sell |
46,875
-533
| -1% | -$22.6K | 0.2% | 107 |
|
|
2019
Q2 | $2.01M | Sell |
47,408
-930
| -2% | -$35.8K | 0.22% | 100 |
|
|
2019
Q1 | $1.85M | Sell |
48,338
-9,321
| -16% | -$356K | 0.21% | 101 |
|
|
2018
Q4 | $2.04M | Buy |
57,659
+5,665
| +11% | +$205K | 0.17% | 82 |
|
|
2018
Q3 | $1.88M | Buy |
51,994
+1,454
| +3% | +$50.8K | 0.15% | 94 |
|
|
2018
Q2 | $1.65M | Sell |
50,540
-6,240
| -11% | -$188K | 0.12% | 144 |
|
|
2018
Q1 | $1.55M | Buy |
56,780
+6,181
| +12% | +$168K | 0.1% | 149 |
|
|
2017
Q4 | $1.25M | Sell |
50,599
-1,591
| -3% | -$43.9K | 0.08% | 201 |
|
|
2017
Q3 | $1.52M | Sell |
52,190
-361
| -0.7% | -$9.97K | 0.1% | 154 |
|
|
2017
Q2 | $1.46M | Sell |
52,551
-2,758
| -5% | -$73.2K | 0.1% | 159 |
|
|
2017
Q1 | $1.38M | Buy |
55,309
+5,665
| +11% | +$138K | 0.09% | 188 |
|
|
2016
Q4 | $1.07M | Buy |
+49,644
| New | +$1.08M | 0.12% | 221 |
|
Other funds holding BSX
Cigna Investments's BSX Position: Q2 2026 in Review
Cigna Investments held its Boston Scientific (BSX) position steady in Q2 2026 at 14,027 shares worth $599K. The position accounts for 0.08% of the portfolio, ranked #221.
Cigna Investments first reported a position in BSX in Q4 2016 and has held it in 39 quarters since. The position peaked at $2.04M in Q4 2018. 1,470 funds tracked by Wall St. Rank hold BSX as of Q2 2026.
- Cigna Investments held 14,027 shares of Boston Scientific worth $599K as of Q2 2026.
- Cigna Investments left its Boston Scientific share count unchanged in Q2 2026.
- Boston Scientific made up 0.08% of Cigna Investments's portfolio in Q2 2026, its #221 holding.
- Cigna Investments first reported a position in Boston Scientific in Q4 2016 and has held it in 39 quarters since.
- Cigna Investments's Boston Scientific position peaked at $2.04M in Q4 2018.
- 1,470 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.
Based on Cigna Investments's 13F filing for Q2 2026, filed 21 Jul 2026.